Bayesian Capital Management »

Apogee Therapeutics shares owned by Bayesian Capital Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by Bayesian Capital Management from 13F filings

Historical chart of Bayesian Capital Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by Bayesian Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by Bayesian Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $698k 12k 58.74
2024-03-31 $450k 6.8k 66.45
2023-09-30 $237k 11k 21.30